dalfopristin and quinupristin (cont.)
IN THIS ARTICLE
What should I discuss with my health care provider before receiving dalfopristin and quinupristin (Synercid)?
You should not receive this medication if you are allergic to dalfopristin and quinupristin.
If you have certain conditions, you may need a dose adjustment or special tests to safely receive this medication. Before you receive dalfopristin and quinupristin, tell your doctor if you are allergic to any drugs, or if you have:
FDA pregnancy category B. This medication is not expected to be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.
It is not known whether dalfopristin and quinupristin passes into breast milk or if it could harm a nursing baby. Do not receive this medication without telling your doctor if you are breast-feeding a baby.
How is dalfopristin and quinupristin given (Synercid)?
Dalfopristin and quinupristin is given as an injection through a needle placed into a vein. Your doctor, nurse, or other healthcare provider will give you this injection.
Dalfopristin and quinupristin is most often given in a hospital setting. The medicine must be given slowly through an IV infusion, and can take up to 1 hour or longer to complete.
Dalfopristin and quinupristin is usually given for at least 7 days, or longer for more severe infections.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
- Questions for Your Pediatrician About Hemophilia
- Treatments for Multiple Myeloma
- New Treatments for Pulmonary Hypertension